A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
Clinical trial NCT05672459 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05672459
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2028-06-29
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.